Cryoport Inc. (CYRX)
NASDAQ
Closed
Oct 8, 2026
Day's Range
16.6552 wk Range
7.61Overview - CYRX - Cryoport Inc.
Key Statistics
Valuation
Enterprise Value
764.41M
P/E (Trailing)
‪12.45‬
P/E (Forward)
‪-26.27‬
PEG Ratio
‪-0.11‬
Price / Sales (TTM)
‪4.73‬
Price / Book
‪1.98‬
EV / EBITDA
‪-221.12‬
Profitability
Gross Margin
‪46.60%‬
Profit Margin
‪-20.05%‬
Operating Margin
‪-20.44%‬
Return on Assets
‪-2.38%‬
Return on Equity
‪-6.54%‬
Ownership
Shares Outstanding
50.64M
Float
45.94M
Short % of Shares Outstanding
‪6.61%‬
Held by Insiders
‪3.85%‬
Held by Institutions
‪95.24%‬
Price stats
Beta
‪1.89‬
50-Day Avg
‪16.01‬
200-Day Avg
‪12.50‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
9 analysts
Average price target
‪$ 19.33‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CYRX - Cryoport Inc.
Peers - CYRX - Cryoport Inc.
Peer Comparison
Compared with companies in Integrated Freight & Logistics listed on NASDAQ.
- CYRXNASDAQCryoport Inc.882.81MMarket Cap+42.74%52-week change12.45P/E (Trailing)‪-20.05%‬Profit Margin
- JBHTNASDAQJ.B. Hunt Transport Services, Inc.21.17BMarket Cap+40.21%52-week change32.07P/E (Trailing)‪5.31%‬Profit Margin
- CHRWNASDAQC.H. Robinson Worldwide Inc.17.49BMarket Cap+11.56%52-week change28.08P/E (Trailing)‪3.72%‬Profit Margin
- LSTRNASDAQLandstar System, Inc.5.73BMarket Cap+26.69%52-week change44.51P/E (Trailing)‪2.63%‬Profit Margin
- HUBGNASDAQHub Group Inc.1.82BMarket Cap-16.73%52-week change17.11P/E (Trailing)‪2.81%‬Profit Margin
- CASHNASDAQPathward Financial Inc.1.53BMarket Cap-0.05%52-week change9.26P/E (Trailing)‪23.38%‬Profit Margin
- FWRDNASDAQForward Air Corporation496.24MMarket Cap-78.69%52-week change10.22P/E (Trailing)‪-11.36%‬Profit Margin
Profile Summary - CYRX - Cryoport Inc.
About
Cryoport Inc. is a global life sciences logistics and services company focused on temperature-controlled supply chain solutions for biologic materials. Cryoport Inc. supports the movement, storage, handling, and monitoring of sensitive products used in cell and gene therapy, biopharmaceuticals, animal health, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
